 Zidovudine therapy capacity phytohemagglutinin-stimulated cells receptors.Pittsburgh AIDS Clinical Trial Unit Zidovudine therapy AIDS patients transient improvements numbers cells vitro functional activities cultured lymphocytes present studies prolonged zidovudine therapy reactivity sensitive assays T-cell function ability phytohemagglutinin PHA cells T-cell colonies capacity receptors growth factor patients periods weeks improvement colony formation time interval plates exogenous mitogen-stimulated significant increase capacity receptors enhanced expression activation cell subset